BioMarin Pharmaceutical reports 6 months of 2022

BioMarin Pharmaceutical's GAAP net income for 6 months of 2022 was $148.46 million, up 389.8% from $30.31 million in the previous year. Revenue increased 6.6% to $1.053 billion from $0.988 billion a year earlier.